Resveratrol increases the pancreatic cancer cells' sensitivity to gemcitabine by its effect on NAF-1 (nutrient-deprivation autophagy factor-1) and Nrf2 signaling. This evidence concerns the gene NAF1 and familial pancreatic carcinoma.